The Challenge of IL-2 Immunotherapy in HIV Disease: “No through Road” or Turning Point?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|6|3|189-199

ISSN： 1570-162X

Source： Current HIV Research, Vol.6, Iss.3, 2008-05, pp. : 189-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The fork in the road: HIV as a potential positive turning point and the role of spirituality

By Kremer H.   Ironson G.   Kaplan L.  

AIDS Care, Vol. 21, Iss. 3, 2009-03 ,pp. : 368-377

Routledge Ltd

Access to resources Recommend Favorite

IL-15 and HIV Infection: Lessons for Immunotherapy and Vaccination

By  

Current HIV Research, Vol. 3, Iss. 3, 2005-07 ,pp. : 261-270

Bentham Science Publishers

Access to resources Recommend Favorite

IL-2, IL-7 and IL-15 as Immuno-Modulators During SIV/HIV Vaccination and Treatment

By  

Current HIV Research, Vol. 7, Iss. 1, 2009-01 ,pp. : 83-90

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory T cells in HIV immunotherapy

By Macatangay Bernard JC   Rinaldo Charles R  

HIV Therapy, Vol. 4, Iss. 6, 2010-11 ,pp. : 639-647

Future Medicine

Access to resources Recommend Favorite

Role of Dendritic Cells in HIV-Immunotherapy

By  

Current HIV Research, Vol. 8, Iss. 4, 2010-06 ,pp. : 310-322

Bentham Science Publishers

Access to resources Recommend Favorite